New surgical stapler shows promise in stomach and lung operations

NCT ID NCT05519215

Completed Disease control Sponsor: Ethicon Endo-Surgery Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new powered stapler (ECHELON 3000) in 244 people having either stomach reduction surgery or lung surgery. The goal was to see if the stapler is safe and works well. Researchers tracked serious problems like infection, bleeding, or air leaks after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LAPAROSCOPIC SLEEVE GASTRECTOMY (LSG) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LAPAROSCOPIC SLEEVE GASTRECTOMY (LSG) THORACIC LUNG RESECTION PROCEDURE

Contacts and locations

Locations

Ascension Providence Hospital

Southfield, Michigan, 48075, United States
Bariatric Medical Institute of Texas

San Antonio, Texas, 78258, United States
Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States
Emory Cardiothoracic Surgery

Atlanta, Georgia, 30322, United States
George Washington University Hospital

Washington D.C., District of Columbia, 20037, United States
Henry Ford Health Center

Detroit, Michigan, 48202, United States
Long Island Jewish Medical Center

New Hyde Park, New York, 11040, United States
Mayo Clinic

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.